Premier Research has added four clinicians to key leadership roles in its pediatric and rare disease clinical research divisions. Dr. Susan P. Tansey, MBCHB, MRCP, CCST, has been appointed medical director of pediatrics. Her medical specialty areas include vaccines, cardiovascular, oncology, neonatology and pediatric medicine. She has considerable experience in pediatric clinical research and trial design. Dr. Tansey joins the company from TMC Pharma Services, where she was director of medical services. She previously had held research positions at Pfizer, Wyeth, and Servier R&D.
Dr. Ilze Balode, a neonatologist and pediatrician, has been named senior project manager at Premier Research Europe based in Latvia. She has global experience in the CRO and pharmaceutical industries with expertise in infectious diseases, pediatric dermatology, central nervous system, oncology, endocrinology, genitourinary, and respiratory conditions. Dr. Balode joins the company from ICON Clinical Research, where she was a project manager.
Dr. Alison Sampson has been named project director at Premier Research Europe, based in the UK. Dr. Sampson is an experienced global clinical trials veteran with expertise in Phase I, II, and III oncology, medical devices, and rare diseases, particularly in pediatrics and neonates. Previously she was project director for oncology at INC Research, UK.
Mary Kay Seeland has been named director of clinical planning and study start-up based in the U.S. Ms. Seeland previously had managed clinical operations at Pharmaceutical Research Associates International (PRA). Prior to that, she held positions in clinical management and regulatory affairs at Amicus Therapeutics and Johnson & Johnson.